NewsDesk

JAKARTA – With the slow development of phase three clinical trials for the Covid-19 vaccine candidate, Indonesia said it had requested data from Brazil, where similar trials were running smoothly.

It is expected to receive safety and efficacy data on Chinese company Sinovac Biotech CoronaVac on December 28, and hopes to finally start rolling out a vaccination program in January.…

This news comes via ChinaPulse.com, which delivers news, data, analysis, and insights on Chinese business, travel, finance, health, military, investment, and technology.